Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Tabcorp Holdings (TAH.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2022-03-255.04-No Rating
2022-07-211.011.00Neutral
2023-02-171.041.05Neutral
2023-02-221.001.09Neutral
2023-08-251.011.11Neutral
2023-10-130.911.02Neutral
2024-02-240.70-No Rating
2024-02-250.701.02Neutral
2024-02-260.740.75Neutral
2024-08-280.480.53Neutral
2024-12-040.540.58Neutral
2025-02-250.680.68Neutral
2025-06-090.70-No Rating

Disclosures

  • UBS Securities Australia Limited is advising Tabcorp Holdings Limited on their proposal to the NSW Government to make changes to the wagering sector, and may receive a fee for acting in this capacity.
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.